Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 7:12:1590102.
doi: 10.3389/fmed.2025.1590102. eCollection 2025.

Phenotyping sarcoidosis: a single institution retrospective analysis

Affiliations

Phenotyping sarcoidosis: a single institution retrospective analysis

Francesco Rocco Bertuccio et al. Front Med (Lausanne). .

Abstract

Introduction: Sarcoidosis is a systemic disorder marked by the presence of non-caseating epithelioid cell granulomas. The diagnosis relies on a consistent clinical presentation, histological evidence of non-necrotizing granulomatous inflammation in one or more tissue specimens, and the exclusion of other potential etiologies of granulomatous disease. It is a heterogeneous disease with many focal points to be clarified. For instance, finding a relationship between symptom burden, race, gender, HRQoL, and pulmonary function could have therapeutic ramifications, influence clinical practice, and aid in selecting patients for specific clinical studies.

Methods: A comprehensive statistical evaluation was conducted using the JMP partitioning algorithm which explores all potential divisions to identify the most predictive variables.

Results: With our analysis, we tried to categorize patients from a single Institution respiratory unit to delineate clinical phenotypes in sarcoidosis.

Conclusions: Larger studies using appropriate methodology should surely be carried out to address this issue and help clarify the varying contributions of genetics, socioeconomic status, environmental exposures, and other sociodemographic factors to illness severity and phenotypic presentation. Additionally, the application of transcriptomics, interdisciplinary methods, patients' disease perspectives, and the publishing of novel discoveries may contribute to enhanced clinical support and a deeper comprehension of the etiology of illness.

Keywords: granulomatous diseases; inflammatory granulomatous diseases; interstitial lung disease; phenotyping; sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Partition for recurrency after treatment related with gender differences.
Figure 2
Figure 2
Partition for Scadding scale.

Similar articles

References

    1. Crouser ED, Maier LA, Baughman RP, Abston E, Bernstein RC, Blankstein R, et al. . Diagnosis and detection of sarcoidosis an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med. (2020) 201:E26–51. 10.1164/rccm.202002-0251ST - DOI - PMC - PubMed
    1. Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, et al. . ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. (2021) 58:2004079. 10.1183/13993003.04079-2020 - DOI - PubMed
    1. Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, et al. . Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. (2016) 13:1244–52. 10.1513/AnnalsATS.201511-760OC - DOI - PubMed
    1. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. (2003) 361:1111–8. 10.1016/S0140-6736(03)12888-7 - DOI - PubMed
    1. Gerke AK. Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med. (2014) 20:472–8. 10.1097/MCP.0000000000000080 - DOI - PMC - PubMed

LinkOut - more resources